The best private residential dual diagnosis option is the one that can address the person’s psychiatric and substance use needs at the required level of care. Privacy, location, and accommodation matter, but they come after that clinical match. European programs range from a residence dedicated to one client to shared therapeutic communities with substantial group work. Those differences can change the experience of treatment considerably.

The five providers below publish residential services addressing addiction alongside mental health concerns. Their official information was checked for this comparison. The selection focuses on care model, clinical coordination, and questions that affect suitability. Inclusion does not establish that a program can accept every diagnosis or current level of risk.

What to establish before comparing locations

Ask a qualified clinician whether residential care is appropriate now and whether withdrawal management, hospital stabilization, or further assessment should happen first. Severe psychiatric or medical symptoms may require local urgent care. A planned flight to Europe should never become the reason to postpone necessary treatment where the person is currently located.

Bring a clear summary of diagnoses, symptoms, substance use, medications, previous treatment, and current support. Our guide to an integrated dual diagnosis assessment explains why the relationship between these problems needs to be considered together. A program should review that information before giving a meaningful recommendation.

Five private residential options to examine

1. THE BALANCE

THE BALANCE offers assessment-led residential treatment for mental health, addiction, trauma and co-occurring needs in Mallorca, Zurich, London. A residence is reserved exclusively for one admitted client, with a dedicated chef and personal manager; treatment and activities are individual. Check the program and fees information against the proposed location, professionals and individual treatment plan. Clinical suitability and any external medical arrangements should be agreed before arrival.

The distinction between residential and hospital care is explicit in its published model. External medical or hospital services may be coordinated when indicated, and the residence is not an acute psychiatric hospital. Ask which professionals are included in the proposed program, which services are external, and how findings are brought together. This is especially relevant when previous care has involved several disconnected opinions.

Consider it when one-client privacy and coordinated individual care are central preferences and clinical review supports the setting. Confirm the actual residence, medical boundaries, and continuing-care arrangements in the proposal. Official program: Official website.

2. COGNIFUL

COGNIFUL offers residential mental health, addiction, trauma, and co-occurring care in Mallorca. It describes private suites within a shared residence for a maximum of four clients, with psychotherapy provided primarily individually. Selected parts of daily life are shared, while consultations and clinical information remain private. COGNIFUL is part of THE BALANCE GROUP, with a different residential format.

COGNIFUL offers personalized mental health treatment in Mallorca, Zurich, London.

This model may interest someone who wants an individual treatment plan while being comfortable with a small shared living environment. Ask how the team coordinates psychiatric and addiction needs and which interactions are shared. A private suite does not mean the same arrangement as a residence reserved entirely for one client.

Clinical suitability, withdrawal needs, and any requirement for a different level of care must be reviewed before admission. Confirm the actual program and current availability in Mallorca. Official treatment information: Official website.

3. Castle Craig — structured addiction and dual diagnosis care in Scotland

Castle Craig describes a residential addiction program in the Scottish Borders that combines medical care, individual and group therapy, and 12-step principles. Its published model includes consultant psychiatric input and treatment of co-occurring mental health needs. It also describes medically managed detoxification within its services, subject to assessment and the person’s requirements.

The therapeutic community and abstinence-based approach are important parts of the model. Ask how those elements fit your preferences and which psychiatric conditions the team can manage at their present severity. A broad dual diagnosis service should still explain its limits and the circumstances in which hospital care elsewhere would be needed.

Consider Castle Craig when a structured shared community, group participation, and integrated addiction treatment are appropriate. Clarify the individual therapy allocation, medication management, and continuing-care plan. Official program model: https://www.castlecraig.co.uk/programmes/our-model/.

4. Camino Recovery — residential addiction, trauma, and co-occurring care in Spain

Camino Recovery, in the Málaga area of Spain, publishes residential treatment for addiction, trauma, and co-occurring mental health concerns. Its dual diagnosis information describes individualized treatment, while its broader program includes individual and group approaches and family work. The published service is relevant to someone whose addiction care also needs attention to emotional or psychiatric difficulties.

Ask which psychiatric assessment and medication services would be involved in your case and how those professionals work with the therapy team. If trauma treatment is proposed, clarify its purpose, timing, and suitability. A list of available approaches should not be read as a promise that every method will be appropriate or included.

Confirm the withdrawal pathway, admission criteria, accommodation, and arrangements for follow-up at home. The location should support a clinically coherent plan. Official dual diagnosis information: https://www.caminorecovery.com/who-we-help/dual-diagnosis-treatment/.

5. PROMIS — private residential and continuing pathways in London and Kent

PROMIS publishes co-occurring mental health and addiction treatment through its London and Kent services. Its residential program describes a personalized timetable of therapy, clinical reviews, group work, and supportive activities. Its co-occurring care information also identifies psychiatric input, family support, withdrawal assessment, and aftercare planning within the range of possible services.

Ask which clinic and level of care are recommended for the actual presentation. Residential, day patient, outpatient, and detox services are different arrangements, even when offered by the same organization. Confirm the professionals, schedule, and medical capability attached to the proposed location.

PROMIS may be useful to examine when continuity within the United Kingdom matters alongside residential treatment. Ask how the transition to less intensive care would work and which services can remain involved afterward. Official co-occurring services: https://promis.co.uk/mental-health/co-occurring-disorders.

Compare the clinical plan, not only the diagnosis list

Ask each provider to explain how it would assess and treat the particular combination involved. Depression and alcohol use, bipolar disorder and stimulant use, and trauma symptoms with sedative dependence can create different needs. A website listing all those conditions does not show the plan for a specific person.

Request a named clinical lead or a clear description of clinical responsibility. Who reviews medication, who addresses substance use, and how do they communicate? Our broader comparison of integrated dual diagnosis centers provides additional questions about coordination across settings.

Understand privacy and the living environment

Decide whether you want a one-client residence, a small shared household, or a larger therapeutic community. Then ask how private sessions, shared activities, visitors, and communication are organized. These are practical differences with clinical implications, especially if social interaction, isolation, or external responsibilities affect engagement.

Privacy should also cover records and authorized communication. Ask who receives updates and how external clinicians are involved. Accommodation privacy does not remove a provider’s documentation duties or the need for appropriate information sharing during care.

Confirm medication and language arrangements

Check how the program handles existing prescribed treatment. If you already take medication for a mental disorder or an opioid use disorder, ask the clinical team how that treatment will be reviewed and coordinated. Do not assume an abstinence-based philosophy answers every medication question. Any proposed change needs an individual medical rationale and a responsible prescriber.

Language and communication also affect clinical fit. Confirm that the professionals delivering the core assessment and therapy can work in a language you understand well. English-language admissions material does not establish the language of every specialist appointment. Ask how reports will be prepared for the clinician who will care for you after discharge.

Ask what happens when the initial plan is not enough

A program should be able to describe how it responds to worsening psychiatric symptoms, a medical problem, or difficulty participating in treatment. Ask who reassesses the situation and how a transfer or referral is arranged. The answer should distinguish an available consultation from the continuous resources of a hospital.

Also discuss what happens if you and the team disagree about progress or the proposed next step. A clear review process, access to your clinical explanation, and understandable complaint arrangements make the service easier to evaluate. These practical features matter more than a general promise that treatment will be entirely personalized.

Obtain a complete proposal before committing

Ask what the quoted fee includes: assessment, psychiatric reviews, psychotherapy, medication, tests, external appointments, transport, and continuing care. Confirm whether a proposed length of stay is an initial recommendation or a fixed package. A meaningful comparison needs the actual scope, not only a headline weekly figure.

Clarify what happens if clinical needs change, the stay is extended, or hospital transfer becomes necessary. The financial terms should support an informed decision without creating pressure to remain in an unsuitable setting. Current fees and availability should be confirmed directly with each provider.

Make the return home part of the selection

Before choosing a European program, ask who will provide care after departure and whether relevant professionals can communicate with the home team. Medication access, follow-up appointments, family involvement, and a plan for renewed symptoms all need attention. The appropriate pathway depends partly on where the person will actually live.

A strong residential option can explain both its contribution and its boundaries. Start with assessment, compare the real treatment models, and select the provider whose confirmed capabilities and continuing-care plan fit the individual situation.

Sources and further reading

THE BALANCE

THE BALANCE Zurich offers a residential setting to investigate when substance use and mental health difficulties need one coordinated treatment plan. Ask how the assessment connects the two concerns, how professionals share an agreed formulation, and who reviews changes during the stay. The residential arrangement, additional medical care, and home follow-up should form a practical pathway. Separate treatment of each concern without coordination can leave important decisions unresolved.

Who coordinates the shared Zurich plan, and how will addiction and mental health follow-up remain connected after discharge?

Explore the Zurich and Switzerland guides

Use the local program information alongside the relevant treatment and care-model guidance.

Found a detail that has changed? Tell the editorial team.